Pacira Pharmaceuticals Presents New Data From EXPAREL Phase 3 Study At Orthopaedic Research Society's 57th Annual Meeting
Links shared publicly online about this topic.
- 581total visits
Pacira Pharmaceuticals Presents New Data From EXPAREL Phase 3 Study At Orthopaedic Research Society's 57th Annual Meeting
Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, announced that new data from its Phase 3 bunionectomy study to evaluate the efficacy and safety of the intraoperative ad
View full resource at medicalnewstoday.com
Tags: Pharma, Phase 3 Clinical Trial, Safety
Most Recently Shared on January 14, 2011 at 3:05 pm By:
Pacira Pharmaceuticals Presents New Data From EXPAREL Phase 3 Study At Orthopaedic Research Society's 57th Annual Meeting http://mnt.to/3Q25
Also Shared By:
Advertisement
MNT Bones/Orthopedic
@mnt_bones
Pacira Pharmaceuticals Presents New Data From EXPAREL Phase 3 Study At Orthopaedic Research Society's 57th Annual Meeting http://mnt.to/3Q25
1 year ago...